A rare case of lupoid leishmaniasis defying diagnosis for a decade
Gehlhausen J, Sibindi C, Ko CJ, Grant M, Zubek A. A rare case of lupoid leishmaniasis defying diagnosis for a decade. Journal Of Cutaneous Pathology 2020, 47: 1054-1057. PMID: 32623733, DOI: 10.1111/cup.13793.Peer-Reviewed Case Reports and Technical NotesConceptsCutaneous leishmaniasisGranulomatous rosaceaPolymerase chain reactionFacial plaquesLupoid leishmaniasisMultiple medical therapiesAcid-fast bacilliExtensive travel historyStandard histopathologic examinationMedical therapyNew lesionsMultiple biopsiesRare presentationHistopathologic examinationGranulomatous diseaseTuberculoid granulomasUltimate diagnosisRare caseSustained improvementEndemic areasSpecial stainsTravel historySarcoidosisCommon diseaseRosaceaDevelopment or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis
Hornick N, Wang A, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Development or worsening of sarcoidosis associated with IL‐17 blockade for psoriasis. Journal Of The European Academy Of Dermatology And Venereology 2020, 34: e583-e585. PMID: 32277505, DOI: 10.1111/jdv.16451.Peer-Reviewed Case Reports and Technical NotesInterleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis
Wang A, Hornick N, Lim Y, Gehlhausen J, Siegel J, Wang J, Foss F, Lim I, Zubek A, Milstone L, Galan A, King B, Damsky W. Interleukin‐17 blockade downregulates NOD2 in skin and may promote paradoxical sarcoidosis. Journal Of The European Academy Of Dermatology And Venereology 2020, 34: e497-e499. PMID: 32249470, DOI: 10.1111/jdv.16416.Peer-Reviewed Case Reports and Technical Notes